The proportion of cancer survivors who met each MetS criterion was as follows: WC >90 cm in men and >80 cm in women, 33.0%; triglyceride levels ≥150 mg/dL or medication use, 20.5%; HDL cholesterol levels <40 mg/dL in men and <50 mg/dL in women or medication use, 28.4%; BP ≥130/85 mmHg or antihypertensive medication use, 40.9%; and FBS levels ≥100 mg/dL or medication use (insulin or oral agents), 77.3%. The gene discussed is INS; the disease is metabolic syndrome.